“Drug Repurposing of Loratadine As a DNMT1 Inhibitor: Comparative Evaluation With Cisplatin in Patient-Derived Oral Squamous Cell Carcinoma Cells”. 2024. Precision Medicine Communications 4 (2): 125-37. https://doi.org/10.55627/pmc.004.02.1083.